Page last updated: 2024-11-02

oxophenylarsine and Leukemia, Basophilic, Acute

oxophenylarsine has been researched along with Leukemia, Basophilic, Acute in 2 studies

oxophenylarsine: inhibits protein-tyrosine-phosphatase
phenylarsine oxide : An arsine oxide derived from phenylarsine.

Leukemia, Basophilic, Acute: A rare acute myeloid leukemia in which the primary differentiation is to BASOPHILS. It is characterized by an extreme increase of immature basophilic granulated cells in the bone marrow and blood. Mature basophils are usually sparse.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kumada, T1
Nakashima, S1
Miyata, H1
Nozawa, Y1
Massol, P1
Montcourrier, P1
Guillemot, JC1
Chavrier, P1

Other Studies

2 other studies available for oxophenylarsine and Leukemia, Basophilic, Acute

ArticleYear
Potent activation of phospholipase D by phenylarsine oxide in rat basophilic leukemia (RBL-2H3) cells.
    Biochemical and biophysical research communications, 1994, Mar-15, Volume: 199, Issue:2

    Topics: Animals; Arsenicals; Benzoquinones; Calcium; Cell Line; Enzyme Activation; Genistein; Isoflavones; K

1994
Fc receptor-mediated phagocytosis requires CDC42 and Rac1.
    The EMBO journal, 1998, Nov-02, Volume: 17, Issue:21

    Topics: Animals; Arsenicals; Bacterial Proteins; Bacterial Toxins; cdc42 GTP-Binding Protein; Cell Cycle Pro

1998